SCHEMBL29059677

SCHEMBL29059677

COc1cc(N2CCC(C(=O)O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2N(C)[S+](C)[O-])n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 11/20 0.61
▸ EGFR P00533 8/20 0.61
▸ MET P08581 2/20 0.60
▸ INSR P06213 8/20 0.60
▸ IGF1R P08069 8/20 0.60
▸ AURKA O14965 2/20 0.60
▸ ROS1 P08922 2/20 0.60
▸ EML4 Q9HC35 1/20 0.60
▸ ZAP70 P43403 1/20 0.59
▸ MAP3K7 O43318 1/20 0.58
▸ MAPK8 P45983 2/20 0.57
▸ MAPK9 P45984 2/20 0.57
▸ MAPK10 P53779 2/20 0.57
▸ CDC7 O00311 1/20 0.57
▸ PLK4 O00444 1/20 0.57
▸ CHEK1 O14757 1/20 0.57
▸ DCLK1 O15075 1/20 0.57
▸ PDPK1 O15530 1/20 0.57
▸ DAPK3 O43293 1/20 0.57
▸ DYRK3 O43781 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29059672 0.91 ALK (0.58) ALKEGFRMETINSRIGF1R
SCHEMBL29059813 0.90 ALK (0.65) ALKEGFRMETINSRIGF1R
SCHEMBL29059803 0.89 ALK (0.62) ALKEGFRMETINSRIGF1R
SCHEMBL29059669 0.89 EGFR (0.62) ALKEGFRINSRIGF1RZAP70
SCHEMBL29059767 0.89 ALK (0.61) ALKEGFRMETINSRIGF1R
SCHEMBL30502332 0.87 ALK (0.60) ALKEGFRMETINSRIGF1R
SCHEMBL29059680 0.86 ALK (0.56) ALKEGFRMETINSRIGF1R
SCHEMBL29059834 0.86 ALK (0.66) ALKEGFRMETINSRIGF1R
SCHEMBL29059696 0.86 EGFR (0.66) ALKEGFRMETINSRIGF1R
SCHEMBL29059678 0.86 ALK (0.74) ALKEGFRINSRIGF1RZAP70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116490184-A Compounds for inhibiting EGFR mutant cancers and pharmaceutical uses thereof J2H生物科技有限公司 2023-07-25 — — CN disclosed
Send feedback